Health·Breaking
Health Canada has authorized an adapted vaccine from Novavax for people age 12 and older to target a variant of COVID-19.
Vaccine targets XBB.1.5 variant circulating globally earlier this year
CBC News · Posted: Dec 05, 2023 3:25 PM EST | Last Updated: 10 minutes ago
Novavax’s vaccine uses a traditional approach to defend the body against COVID-19. (Dado Ruvic illustration/Reuters)
Health Canada has authorized an adapted vaccine from Novavax to prevent COVID-19 in people age 12 and older.
The vaccine uses a traditional approach to defend the body against COVID.
It contains a version of the viral spike
